M.F. El-Asmar

857 total citations
38 papers, 731 citations indexed

About

M.F. El-Asmar is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, M.F. El-Asmar has authored 38 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 29 papers in Genetics and 13 papers in Pharmacology. Recurrent topics in M.F. El-Asmar's work include Venomous Animal Envenomation and Studies (27 papers), Ion channel regulation and function (14 papers) and Healthcare and Venom Research (9 papers). M.F. El-Asmar is often cited by papers focused on Venomous Animal Envenomation and Studies (27 papers), Ion channel regulation and function (14 papers) and Healthcare and Venom Research (9 papers). M.F. El-Asmar collaborates with scholars based in Egypt, United States and Sudan. M.F. El-Asmar's co-authors include M. Ismail, O.H. Osman, Anthony T. Tu, Mohamed Talaat Abdel Aziz, Gerald Soslau, Hanan Hassan Ahmed, Hanan Fouad, F. Taha, Hazem Atta and A.A. Abdel-Rahman and has published in prestigious journals such as Biochemistry, Biochemical and Biophysical Research Communications and CHEST Journal.

In The Last Decade

M.F. El-Asmar

38 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.F. El-Asmar Egypt 18 455 391 175 77 75 38 731
Leigh A. Jania United States 15 85 0.2× 441 1.1× 132 0.8× 123 1.6× 55 0.7× 22 834
Thalita Rocha Brazil 14 184 0.4× 162 0.4× 71 0.4× 34 0.4× 9 0.1× 51 543
Christopher Ford United Kingdom 14 65 0.1× 411 1.1× 16 0.1× 91 1.2× 14 0.2× 21 952
Hakan Savlı Türkiye 15 107 0.2× 424 1.1× 24 0.1× 30 0.4× 95 1.3× 45 779
David O. Peterson United States 21 238 0.5× 591 1.5× 32 0.2× 14 0.2× 17 0.2× 39 995
Noriko Kondo Japan 15 132 0.3× 615 1.6× 44 0.3× 35 0.5× 55 0.7× 33 928
Dezhong Yin United States 14 64 0.1× 330 0.8× 18 0.1× 36 0.5× 26 0.3× 21 502
Vikram Rajagopal India 8 26 0.1× 178 0.5× 39 0.2× 84 1.1× 38 0.5× 9 505
Elaine Holland United Kingdom 13 58 0.1× 264 0.7× 165 0.9× 260 3.4× 34 0.5× 17 720
Vaseem A. Palejwala United States 14 155 0.3× 365 0.9× 32 0.2× 73 0.9× 5 0.1× 33 594

Countries citing papers authored by M.F. El-Asmar

Since Specialization
Citations

This map shows the geographic impact of M.F. El-Asmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.F. El-Asmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.F. El-Asmar more than expected).

Fields of papers citing papers by M.F. El-Asmar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.F. El-Asmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.F. El-Asmar. The network helps show where M.F. El-Asmar may publish in the future.

Co-authorship network of co-authors of M.F. El-Asmar

This figure shows the co-authorship network connecting the top 25 collaborators of M.F. El-Asmar. A scholar is included among the top collaborators of M.F. El-Asmar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.F. El-Asmar. M.F. El-Asmar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aziz, Mohamed Talaat Abdel, M.F. El-Asmar, Soheir Mahfouz, et al.. (2013). The effect of a novel curcumin derivative on pancreatic islet regeneration in experimental type-1 diabetes in rats (long term study). Diabetology & Metabolic Syndrome. 5(1). 75–75. 35 indexed citations
2.
Aziz, Mohamed Talaat Abdel, M.F. El-Asmar, Abdulrahman L. Al‐Malki, et al.. (2012). Effect of novel water soluble curcumin derivative on experimental type- 1 diabetes mellitus (short term study). Diabetology & Metabolic Syndrome. 4(1). 30–30. 58 indexed citations
3.
Aziz, Mohamed Talaat Abdel, M.F. El-Asmar, Hanan Fouad, et al.. (2012). Novel Anticancer Curcumin Derivative with Conserved Functional Groups. 1(1). 10–10. 8 indexed citations
4.
Aziz, M. T. Abdel, M.F. El-Asmar, Taymour Mostafa, et al.. (2008). Effect of Hemin and Carbon Monoxide Releasing Molecule (CORM-3) on cGMP in Rat Penile Tissue. The Journal of Sexual Medicine. 5(2). 336–343. 16 indexed citations
5.
Aziz, Mohamed Talaat Abdel, M.F. El-Asmar, Hazem Atta, et al.. (2005). Gene Expression of Heme Oxygenase-1: Relationship to Fibrogenic and Apoptotic Factors in Murine Schistosomiasis. Journal of Clinical Biochemistry and Nutrition. 36(3). 67–78. 2 indexed citations
6.
El-Asmar, M.F., et al.. (2003). Retrovirus-mediated human heme oxygenase-1 (HO-1) gene transfer into rat endothelial cells: the effect of HO-1 inducers on the expression of cytokines. The International Journal of Biochemistry & Cell Biology. 35(3). 324–332. 25 indexed citations
7.
El-Asmar, M.F., et al.. (1995). Characterization of a potent platelet aggregation inducer from Cerastes cerastes (Egyptian sand viper) venom. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1250(1). 97–109. 18 indexed citations
8.
El-Asmar, M.F., et al.. (1993). Low molecular weight factor X activator from Cerastes Vipera (Sahara sand viper) venom. Toxicon. 31(8). 1007–1017. 14 indexed citations
10.
Tu, Anthony T., et al.. (1990). Effect of Cerastobin, a Thrombinlike Enzyme from Cerastes vipera (Egyptian Sand Snake) Venom, on Human Platelets. Pathophysiology of Haemostasis and Thrombosis. 20(5). 296–304. 8 indexed citations
11.
Tu, Anthony T., et al.. (1989). Characterization of cerastobin, a thrombin-like enzyme from the venom of Cerastes vipera (Sahara sand viper). Biochemistry. 28(1). 371–377. 46 indexed citations
12.
Soslau, Gerald, M.F. El-Asmar, & Jordan Parker. (1988). Cerastes cerastes (Egyptian Sand Viper) venom induced platelet aggregation as compared to other agonists. Biochemical and Biophysical Research Communications. 150(3). 909–916. 23 indexed citations
13.
El-Asmar, M.F. & J B Swaney. (1988). Proteolysis in vitro of low and high density lipoproteins in human plasma by Cerastes cerastes (Egyptian sand viper) venom. Toxicon. 26(9). 809–816. 6 indexed citations
14.
El-Asmar, M.F., et al.. (1987). Further characterization of the anticoagulant proteinase, cerastase F-4 from cerastes cerastes (Egyptian sand viper) venom. Toxicon. 25(8). 891–897. 17 indexed citations
15.
El-Asmar, M.F., et al.. (1987). Purification and characterization of phosphodiesterase (exonuclease) from Cerastes cerastes (Egyptian sand viper) venom. Toxicon. 25(11). 1199–1207. 10 indexed citations
16.
El-Asmar, M.F., et al.. (1986). Coagulant component in Cerastes cerastes (Egyptian sand viper) venom. Toxicon. 24(11-12). 1037–1044. 29 indexed citations
17.
El-Asmar, M.F., et al.. (1980). Factor(s) in the venom of scorpions toxic to Schistosoma mansoni (intestinal belharzia) cercariae. Toxicon. 18(5-6). 711–715. 10 indexed citations
18.
Ismail, M., K.A. Gumaa, O.H. Osman, & M.F. El-Asmar. (1978). Effect of Buthus minax (L. Koch) scorpion venom on plasma and urinary electrolyte levels. Toxicon. 16(4). 385–392. 22 indexed citations
19.
El-Asmar, M.F., O.H. Osman, & M. Ismail. (1973). Fractionation and lethality of venom from the scorpion Buthus minax (L. Koch). Toxicon. 11(1). 3–7. 12 indexed citations
20.
Osman, O.H., M. Ismail, & M.F. El-Asmar. (1973). Pharmacological studies of snake (Dendroaspis angusticeps) venom. Toxicon. 11(2). 185–192. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026